Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Warfarin vs Aspirin for Recurrent Ischemic Stroke Prevention
NCT00027066Phase 3Completed
- Sponsor
- Columbia University
- Start
- Jun 1993
- Primary completion
- Jun 2000
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of warfarin and aspirin in ischemic stroke (2 arms), sponsored by Columbia University. Started Jun 1993; status: completed.
02
Drugs
warfarinaspirin
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT00027066.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00027066.